molecular-diagnostics | LabMedica International Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
 https://www.labmedica.com Tue, 15 Sep 2026 14:31:54 +0100 FeedCreator 1.7.2 Blood-Based DNA Analysis Method Detects Early-Stage Solid Cancers https://www.labmedica.com/molecular-diagnostics/articles/294813028/blood-based-dna-analysis-method-detects-early-stage-solid-cancers.html A new liquid biopsy detects stage I/II solid cancers from plasma ctDNA with 95% early-stage sensitivity. Blood-Based DNA Analysis Method Detects Early-Stage Solid Cancers - Blood-Based DNA Analysis Method Detects Early-Stage Solid Cancers Tue, 15 Sep 2026 09:57:12 +0100 Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset https://www.labmedica.com/molecular-diagnostics/articles/294813025/combined-blood-and-genetic-tests-estimate-timing-of-alzheimers-symptom-onset.html A combined blood-based Alzheimer’s marker and genetic risk test estimates time to symptom onset within 3–6 years in asymptomatic adults. Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset - Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset Mon, 14 Sep 2026 10:10:35 +0100 Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants https://www.labmedica.com/molecular-diagnostics/articles/294813022/blood-protein-analysis-helps-interpret-uncertain-rare-disease-variants.html A new blood proteomics–genomics approach improves interpretation of uncertain variants and supports rare disease diagnosis. Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants - Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants Sat, 12 Sep 2026 12:26:57 +0100 40-Gene Test Validated for High-Risk Squamous Cell Carcinoma https://www.labmedica.com/molecular-diagnostics/articles/294812979/40-gene-test-validated-for-high-risk-squamous-cell-carcinoma.html An integrated 40‑gene expression test improves prognostic accuracy and guides adjuvant radiation in high‑risk cSCC. 40-Gene Test Validated for High-Risk Squamous Cell Carcinoma - 40-Gene Test Validated for High-Risk Squamous Cell Carcinoma Thu, 10 Sep 2026 14:58:31 +0100 Common Genetic Marker Predicts Faster Motor Decline in Parkinson’s Disease https://www.labmedica.com/molecular-diagnostics/articles/294812971/common-genetic-marker-predicts-faster-motor-decline-in-parkinsons-disease.html Researchers identify common genetic variants as markers of faster motor decline in Parkinson’s disease. Common Genetic Marker Predicts Faster Motor Decline in Parkinson’s Disease - Common Genetic Marker Predicts Faster Motor Decline in Parkinson’s Disease Thu, 10 Sep 2026 11:05:53 +0100